![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | RGD:1553533 | 6480464 | ethylene dichloride results in decreased expression of SYDE1 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1553533 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of SYDE1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1602201 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of SYDE1 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553533 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SYDE1 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYDE1 mRNA | CTD | PMID:22298810 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SYDE1 mRNA | CTD | PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SYDE1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | RGD:1602201 | 6480464 | Aflatoxin B1 results in increased expression of SYDE1 mRNA | CTD | PMID:22100608 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of SYDE1 mRNA | CTD | PMID:30047161 | arsane | multiple interactions | ISO | RGD:1602201 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYDE1 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | RGD:1602201 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYDE1 mRNA | CTD | PMID:32525701 | benzo[a]pyrene | decreases expression | ISO | RGD:1553533 | 6480464 | Benzo(a)pyrene results in decreased expression of SYDE1 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | RGD:1602201 | 6480464 | Benzo(a)pyrene results in increased expression of SYDE1 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | RGD:1602201 | 6480464 | Benzo(a)pyrene results in decreased methylation of SYDE1 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1602201 | 6480464 | Benzo(a)pyrene results in increased methylation of SYDE1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SYDE1 mRNA | CTD | PMID:21839799 | beta-naphthoflavone | decreases expression | ISO | RGD:1602201 | 6480464 | beta-Naphthoflavone results in decreased expression of SYDE1 mRNA | CTD | PMID:32858204 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SYDE1 mRNA | CTD | PMID:25181051 | cadmium dichloride | decreases expression | ISO | RGD:1602201 | 6480464 | Cadmium Chloride results in decreased expression of SYDE1 mRNA | CTD | PMID:26472689 | calcitriol | increases expression | ISO | RGD:1602201 | 6480464 | Calcitriol results in increased expression of SYDE1 mRNA | CTD | PMID:16002434 | carbon nanotube | decreases expression | ISO | RGD:1553533 | 6480464 | Nanotubes, Carbon analog results in decreased expression of SYDE1 mRNA | CTD | PMID:25554681 | cisplatin | decreases expression | ISO | RGD:1602201 | 6480464 | Cisplatin results in decreased expression of SYDE1 mRNA | CTD | PMID:27392435 | coumarin | decreases phosphorylation | ISO | RGD:1602201 | 6480464 | coumarin results in decreased phosphorylation of SYDE1 protein | CTD | PMID:35688186 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of SYDE1 mRNA | CTD | PMID:23640034 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SYDE1 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | RGD:1602201 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYDE1 mRNA | CTD | PMID:27188386 | doxorubicin | affects response to substance | ISO | RGD:1602201 | 6480464 | SYDE1 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | doxorubicin | decreases expression | ISO | RGD:1602201 | 6480464 | Doxorubicin results in decreased expression of SYDE1 mRNA | CTD | PMID:29803840 | fenamidone | increases expression | ISO | RGD:1553533 | 6480464 | fenamidone results in increased expression of SYDE1 mRNA | CTD | PMID:27029645 | fluoranthene | multiple interactions | ISO | RGD:1553533 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of SYDE1 mRNA | CTD | PMID:28329830 | fonofos | increases methylation | ISO | RGD:1602201 | 6480464 | Fonofos results in increased methylation of SYDE1 promoter | CTD | PMID:22847954 | hydrogen peroxide | multiple interactions | ISO | RGD:1553533 | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | RGD:1602201 | 6480464 | Arbutin results in decreased expression of SYDE1 mRNA | CTD | PMID:17103032 | leflunomide | decreases expression | ISO | RGD:1602201 | 6480464 | leflunomide results in decreased expression of SYDE1 mRNA | CTD | PMID:28988120 | lipopolysaccharide | multiple interactions | ISO | RGD:1602201 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SYDE1 mRNA | CTD | PMID:35811015 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of SYDE1 mRNA | CTD | PMID:30047161 | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of SYDE1 mRNA | CTD | PMID:23665939 | ozone | multiple interactions | ISO | RGD:1553533 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SYDE1 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | RGD:1553533 | 6480464 | Acetaminophen affects the expression of SYDE1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | RGD:1602201 | 6480464 | Acetaminophen results in decreased expression of SYDE1 mRNA | CTD | PMID:29067470 | parathion | increases methylation | ISO | RGD:1602201 | 6480464 | Parathion results in increased methylation of SYDE1 promoter | CTD | PMID:22847954 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1602201 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SYDE1 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | RGD:1602201 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYDE1 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases methylation | ISO | RGD:1602201 | 6480464 | Silicon Dioxide results in decreased methylation of SYDE1 gene | CTD | PMID:34973136 | silicon dioxide | increases expression | ISO | RGD:1602201 | 6480464 | Silicon Dioxide results in increased expression of SYDE1 mRNA | CTD | PMID:34973136 | sodium arsenate | multiple interactions | ISO | RGD:1602201 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYDE1 mRNA | CTD | PMID:32525701 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SYDE1 mRNA | CTD | PMID:19281266 | sulindac sulfide | increases expression | ISO | RGD:1602201 | 6480464 | sulindac sulfide results in increased expression of SYDE1 mRNA | CTD | PMID:12734198 | temozolomide | increases expression | ISO | RGD:1602201 | 6480464 | Temozolomide results in increased expression of SYDE1 mRNA | CTD | PMID:31758290 | terbufos | increases methylation | ISO | RGD:1602201 | 6480464 | terbufos results in increased methylation of SYDE1 promoter | CTD | PMID:22847954 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SYDE1 mRNA | CTD | PMID:34492290 | urethane | decreases expression | ISO | RGD:1602201 | 6480464 | Urethane results in decreased expression of SYDE1 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | RGD:1602201 | 6480464 | Valproic Acid results in increased methylation of SYDE1 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | RGD:1602201 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYDE1 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | RGD:1602201 | 6480464 | Valproic Acid results in decreased expression of SYDE1 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | RGD:1602201 | 6480464 | Valproic Acid affects the expression of SYDE1 mRNA | CTD | PMID:25979313 | vincaleukoblastine | affects response to substance | ISO | RGD:1602201 | 6480464 | SYDE1 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | vitamin E | increases expression | ISO | RGD:1602201 | 6480464 | Vitamin E results in increased expression of SYDE1 mRNA | CTD | PMID:19244175 | |